Voxtalisib

CAS No. 934493-76-2

Voxtalisib ( XL765;SAR245409;SAR-245409;XL 765;XL-765 )

Catalog No. M16680 CAS No. 934493-76-2

A potent, highly selective ATP-competitive inhibitor of class I PI3Ks.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 In Stock
5MG 65 In Stock
10MG 113 In Stock
25MG 227 In Stock
50MG 365 In Stock
100MG 531 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Voxtalisib
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, highly selective ATP-competitive inhibitor of class I PI3Ks.
  • Description
    A potent, highly selective ATP-competitive inhibitor of class I PI3Ks with IC50s of 39/110/43/9 nM for p110α/p110β/p110δ/p120γ; also inhibits mTORC1/mTORC2/DNA-PK (IC50=160/910/150 nM) and shows weak inhibitory activity toward VPS34 (IC50=9.1 uM); inhibits phosphorylation of AKT, p70S6K, and S6 phosphorylation in multiple tumor cell lines; orally bioactive in mouse xenograft models.Solid Tumors Phase 2 Clinical
  • Synonyms
    XL765;SAR245409;SAR-245409;XL 765;XL-765
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    DNA-PK;PI3Kα;PI3Kβ;PI3Kγ;PI3Kδ
  • Research Area
    Cancer
  • Indication
    Solid Tumors

Chemical Information

  • CAS Number
    934493-76-2
  • Formula Weight
    270.29
  • Molecular Formula
    C13H14N6O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 16 mg/mL
  • SMILES
    O=C1C(C2=CC=NN2)=CC3=C(C)N=C(N)N=C3N1CC
  • Chemical Name
    Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-3-yl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yu P, et al. Mol Cancer Ther. 2014 May;13(5):1078-91.
2. Papadopoulos KP, et al. Clin Cancer Res. 2014 May 1;20(9):2445-56.
3. Thijssen R, et al. Leukemia. 2016 Feb;30(2):337-45.
molnova catalog
related products
  • PIK-294

    A highly potent, selective p110δ inhibitor with IC50 of 10 nM.

  • Voxtalisib

    A potent, highly selective ATP-competitive inhibitor of class I PI3Ks.

  • Idelalisib

    Idelalisib (CAL-101, GS-1101) is a potent, selective inhibitor of PI3K p110δ with IC50 of 2.5 nM.